University Hospitals Health System is an independent non-profit healthcare organization based in Cleveland, Ohio, established in 1866. It provides a comprehensive range of medical services, including primary and specialty care, nursing, elder healthcare, rehabilitation, and home care services. University Hospitals Home Care Services Inc., a division of the system, offers both medical and non-medical services to patients in their homes, such as skilled nursing, physical therapy, social work, nutritional counseling, and personal care. The organization is committed to meeting the healthcare needs of northeast Ohio through strategic geographic expansion and diversification of services. Its leadership team oversees the management of the health system's assets, ensuring the delivery of quality care to the community.
Axuall, Inc. is a workforce intelligence company that operates a digital network designed to verify identities, credentials, and authenticity across various sectors, including healthcare, insurance, and logistics. Founded in 2018 and based in Cleveland, Ohio, Axuall offers an integrated platform that facilitates smarter decision-making and expedites the onboarding process for healthcare providers. By leveraging real-time practitioner data, the company enhances workforce deployment and efficiency, and provides critical insights for network planning, analytics, and reporting. Its solutions aim to empower healthcare professionals by granting them control over their career identities while connecting health systems, staffing firms, and telehealth organizations to valuable data resources.
STAQ Pharma
Series C in 2022
STAQ Pharma, Inc. is a Denver-based company that specializes in manufacturing and selling compounded pharmaceutical medications. Founded in 2018, it operates a current Good Manufacturing Practice (cGMP) outsourcing facility that produces a range of compounded medications, including sterile solutions and prefilled syringes for hospital procedures. The company emphasizes safety, quality, and transparency in its offerings, providing healthcare facilities with reliable access to these critical products. STAQ Pharma sells its medications through its own pharmaceutical facilities and an online store, ensuring that inventory systems are in place to forecast needs and proactively supply partners with essential medications.
Babyscripts
Series B in 2021
Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.
BioMotiv
Venture Round in 2013
BioMotiv is a therapeutic accelerator established in 2012 and headquartered in Cleveland, Ohio. It focuses on developing a portfolio of novel medicines as part of The Harrington Project for Discovery and Development, a significant initiative aimed at transforming the drug advancement process. Launched by University Hospitals, this $250 million project aims to align the research capabilities of the Harrington Discovery Institute with the development efforts of BioMotiv, thereby accelerating the innovation of therapeutics for the benefit of patients worldwide. BioMotiv primarily invests in companies within the healthcare and life sciences sectors, supporting advancements that promise to deliver breakthrough drugs to market more efficiently.
BioMotiv
Venture Round in 2012
BioMotiv is a therapeutic accelerator established in 2012 and headquartered in Cleveland, Ohio. It focuses on developing a portfolio of novel medicines as part of The Harrington Project for Discovery and Development, a significant initiative aimed at transforming the drug advancement process. Launched by University Hospitals, this $250 million project aims to align the research capabilities of the Harrington Discovery Institute with the development efforts of BioMotiv, thereby accelerating the innovation of therapeutics for the benefit of patients worldwide. BioMotiv primarily invests in companies within the healthcare and life sciences sectors, supporting advancements that promise to deliver breakthrough drugs to market more efficiently.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.